Global Patent Index - EP 1044273 A2

EP 1044273 A2 2000-10-18 - COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE

Title (en)

COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE

Title (de)

VON MYCOBACTERIUM VACCAE ABGELEITETE ZUSAMMENSETZUNGEN UND METHODEN FÜR IHRE VERWENDUNG

Title (fr)

COMPOSITIONS DERIVEES DE $i(MYCOBACTERIUM VACCAE) ET LEURS METHODES D'UTILISATION

Publication

EP 1044273 A2 (EN)

Application

EP 98963665 A

Priority

  • NZ 9800189 W
  • US 99736297 A
  • US 99708097 A
  • US 99662497 A
  • US 9585598 A
  • US 15618198 A
  • US 20542698 A

Abstract (en)

[origin: WO9932634A2] The present invention provides compositions which are present in or may be derived from Mycobacterium vaccae, together with methods for their use in the treatment, prevention and detection of disorders including infectious diseases, immune disorders and cancer. Methods for enhancing the immune response to an antigen including administration of M. vaccae culture filtrate, delipidated M. vaccae cells, delipidated and deglycolipidated M. vaccae cells depleted of mycolic acids, and delipidated and deglycolipidated M.vaccae cells depleted of mycolic acids and arabinogalactan are also provided.

IPC 1-7 (main, further and additional classification)

C12N 15/31; A61K 39/04; A61K 48/00; C07K 14/35; C07K 16/12; C07K 19/00; C12N 15/62; G01N 33/68

IPC 8 full level (invention and additional information)

G01N 33/569 (2006.01); A61K 31/711 (2006.01); A61K 39/04 (2006.01); A61K 48/00 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 17/00 (2006.01); A61P 17/06 (2006.01); A61P 31/00 (2006.01); A61P 31/06 (2006.01); A61P 37/04 (2006.01); C07K 14/35 (2006.01); C07K 16/12 (2006.01); C07K 19/00 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/31 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); G01N 33/68 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); C12R 1/32 (2006.01)

CPC (invention and additional information)

C07K 14/35 (2013.01); A61K 39/04 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 48/00 (2013.01); A61K 2039/51 (2013.01); C07K 2319/00 (2013.01)

Citation (search report)

See references of WO 9932634A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9932634 A2 19990701; WO 9932634 A3 19991202; AU 1893699 A 19990712; AU 746311 B2 20020418; BR 9814432 A 20001010; CA 2315539 A1 19990701; CN 1294632 A 20010509; EP 1044273 A2 20001018; HU 0100352 A2 20010628; ID 26327 A 20001214; IL 136821 D0 20010614; JP 2002514385 A 20020521; MX PA00006168 A 20050224; NO 20003261 A 20000822; NO 20003261 D0 20000622; NZ 505834 A 20021220; PL 341697 A1 20010423; TR 200001948 T2 20010221

INPADOC legal status


2005-03-02 [18D] DEEMED TO BE WITHDRAWN

- Ref Legal Event Code: 18D

- Effective date: 20040817

2004-05-19 [17Q] FIRST EXAMINATION REPORT

- Ref Legal Event Code: 17Q

- Effective date: 20040406

2000-10-18 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20000714

2000-10-18 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE